HCWB
Price
$1.09
Change
-$0.06 (-5.17%)
Updated
Jun 23, 03:55 PM (EDT)
Capitalization
8.31M
45 days until earnings call
Intraday BUY SELL Signals
XLO
Price
$9.05
Change
+$0.11 (+1.23%)
Updated
Jun 23, 03:49 PM (EDT)
Capitalization
59.37M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HCWB vs XLO

HCWB vs XLO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HCWB vs. XLO commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCWB is a Hold and XLO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (HCWB: $1.16 vs. XLO: $9.03)
Brand notoriety: HCWB and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HCWB: 25% vs. XLO: 55%
Market capitalization -- HCWB: $8.31M vs. XLO: $59.37M
HCWB [@Biotechnology] is valued at $8.31M. XLO’s [@Biotechnology] market capitalization is $59.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HCWB’s FA Score shows that 1 FA rating(s) are green whileXLO’s FA Score has 1 green FA rating(s).

  • HCWB’s FA Score: 1 green, 4 red.
  • XLO’s FA Score: 1 green, 4 red.
According to our system of comparison, both HCWB and XLO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HCWB’s TA Score shows that 3 TA indicator(s) are bullish while XLO’s TA Score has 5 bullish TA indicator(s).

  • HCWB’s TA Score: 3 bullish, 5 bearish.
  • XLO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, XLO is a better buy in the short-term than HCWB.

Price Growth

HCWB (@Biotechnology) experienced а -4.92% price change this week, while XLO (@Biotechnology) price change was +8.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

HCWB is expected to report earnings on Aug 07, 2026.

XLO is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XLO($59.4M) has a higher market cap than HCWB($8.31M). HCWB YTD gains are higher at: 19.514 vs. XLO (0.750). HCWB has higher annual earnings (EBITDA): -350.28K vs. XLO (-40.86M). XLO has more cash in the bank: 150M vs. HCWB (1.23M). HCWB (6.58M) and XLO (6.64M) have identical debt. XLO has higher revenues than HCWB: XLO (53.5M) vs HCWB (6.59M).
HCWBXLOHCWB / XLO
Capitalization8.31M59.4M14%
EBITDA-350.28K-40.86M1%
Gain YTD19.5140.7502,603%
P/E RatioN/AN/A-
Revenue6.59M53.5M12%
Total Cash1.23M150M1%
Total Debt6.58M6.64M99%
TECHNICAL ANALYSIS
Technical Analysis
HCWBXLO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
HCWB
Daily Signal:
Gain/Loss:
XLO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRBK19.160.33
+1.75%
SR Bancorp
HDL12.58N/A
N/A
Super Hi International Holding Ltd ADR
DTSS0.76N/A
-0.01%
Datasea Intelligent Technology Ltd.
WSM226.06-0.86
-0.38%
Williams-Sonoma
BETA15.73-0.37
-2.30%
BETA Technologies Inc

HCWB and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCWB has been loosely correlated with APLM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HCWB jumps, then APLM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCWB
1D Price
Change %
HCWB100%
+6.42%
APLM - HCWB
45%
Loosely correlated
+30.47%
GDTC - HCWB
35%
Loosely correlated
N/A
IVVD - HCWB
34%
Loosely correlated
-5.57%
GHRS - HCWB
32%
Poorly correlated
-0.97%
XLO - HCWB
30%
Poorly correlated
+2.73%
More

XLO and

Correlation & Price change

A.I.dvisor tells us that XLO and VYGR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLO and VYGR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
+2.73%
VYGR - XLO
32%
Poorly correlated
N/A
BLRX - XLO
31%
Poorly correlated
+2.53%
CRMD - XLO
31%
Poorly correlated
+1.50%
AXON - XLO
31%
Poorly correlated
-3.16%
HCWB - XLO
29%
Poorly correlated
+6.42%
More